STAT+: Dana-Farber retracts string of studies in systematic review of data integrity
STAT
APRIL 18, 2024
An ongoing investigation into data integrity at Dana-Farber Cancer Institute has resulted in a string of retractions, the latest of which is a 2006 Science paper co-authored by institute president and CEO Laurie Glimcher.
Let's personalize your content